Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease thromboembolism
Phenotype C0027726|nephrotic syndrome
Sentences 11
PubMedID- 24078010 Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters.
PubMedID- 26220221 Negative d-dimer may exclude venous thromboembolism in patients with nephrotic syndrome.
PubMedID- 23439670 thromboembolism in patients with nephrotic syndrome is a well-known complication because of hypercoagulable state and many other factors like hemoconcentration, increased blood viscosity, hypoalbuminemia, alteration in platelet function, and possibly administration of steroids and/or diuretics.
PubMedID- 21886984 Cerebral infarction due to arterial thromboembolism in adults with nephrotic syndrome has been rarely reported.
PubMedID- 25018941 High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
PubMedID- 24803917 Carotid thromboembolism associated with nephrotic syndrome treated with dabigatran.
PubMedID- 23613095 Prophylaxis of thromboembolic events in patients with nephrotic syndrome.
PubMedID- 23081957 The purpose of this essay is to describe the epidemiology, pathophysiological mechanisms, the imaging diagnosis, and treatment of thromboembolism in patients with nephrotic syndrome.
PubMedID- 20886026 nephrotic syndrome is complicated by venous thromboembolism sufficiently frequently for the diagnosis to be considered in all patients with deep venous thromboembolism or pulmonary embolism.
PubMedID- 24334865 Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.
PubMedID- 24068403 Background: the risk of thromboembolic events is increased in patients with nephrotic syndrome (ns) as compared with other medical conditions and is a severe complication associated with significant morbidity and mortality.

Page: 1